• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷Rb1对小鼠肠道缺血再灌注诱导的急性肾损伤的保护作用。

Protective effect of ginsenoside Rb1 against intestinal ischemia-reperfusion induced acute renal injury in mice.

作者信息

Sun Qian, Meng Qing-tao, Jiang Ying, Liu Hui-min, Lei Shao-qing, Su Wa-ting, Duan Wei-na, Wu Yang, Xia Zheng-yuan, Xia Zhong-yuan

机构信息

Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

出版信息

PLoS One. 2013 Dec 4;8(12):e80859. doi: 10.1371/journal.pone.0080859. eCollection 2013.

DOI:10.1371/journal.pone.0080859
PMID:24324637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3851764/
Abstract

Ginsenoside Rb1 (RB1), the most clinically effective constituent of ginseng, possesses a variety of biological activities. The objectives of this study were to investigate the protective effects of RB1 and its underlying mechanism on renal injury induced by intestinal ischemia-reperfusion (IIR) in mice. RB1 was administered prior to inducing IIR achieved by occluding the superior mesenteric artery for 45 min followed by 120 min of reperfusion. All-trans-retinoic acid (ATRA) was used as an inhibitor of NF-E2-related factor-2 (Nrf2) signaling. Adult male C57BL/6J mice were randomly divided into six groups: (1) sham group, (2) IIR group, (3) RB1 group, (4) sham + ATRA group, (5) IIR + ATRA group, and (6) RB1 + ATRA group. Intestinal histology and pathological injury score were observed. Intestinal mucosal injury was also evaluated by measuring serum diamine oxidase (DAO). Renal injury induced by IIR was characterized by increased levels of histological severity score, blood urea nitrogen (BUN), serum creatinine (Scr) and neutrophil gelatinase-associated lipocalin (NGAL), which was accompanied with elevated renal TUNEL-positive cells and the Bcl-2/Bax expression ratio. RB1 significantly reduced renal injury and apoptosis as compared with IIR group, which was reversed by ATRA treatment. Immunohistochemistry and Western blot analysis demonstrated that RB1 significantly upregulated the protein expression of heme oxygenase-1 (HO-1) and Nrf2, which were attenuated by ATRA treatment. Taken together, these results suggest that the protective effects of RB1 pretreatment against renal injury induced by IIR are associated with activation of the Nrf2/ anti-oxidant response element (ARE) pathway.

摘要

人参皂苷Rb1(RB1)是人参中临床疗效最为显著的成分,具有多种生物活性。本研究旨在探讨RB1对小鼠肠缺血再灌注(IIR)诱导的肾损伤的保护作用及其潜在机制。在通过阻断肠系膜上动脉45分钟,然后再灌注120分钟诱导IIR之前给予RB1。全反式维甲酸(ATRA)用作NF-E2相关因子2(Nrf2)信号通路的抑制剂。成年雄性C57BL/6J小鼠随机分为六组:(1)假手术组,(2)IIR组,(3)RB1组,(4)假手术+ATRA组,(5)IIR+ATRA组,和(6)RB1+ATRA组。观察肠道组织学和病理损伤评分。还通过测量血清二胺氧化酶(DAO)评估肠黏膜损伤。IIR诱导的肾损伤表现为组织学严重程度评分、血尿素氮(BUN)、血清肌酐(Scr)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平升高,同时伴有肾TUNEL阳性细胞和Bcl-2/Bax表达比值升高。与IIR组相比,RB1显著减轻了肾损伤和细胞凋亡,而ATRA处理可逆转这种作用。免疫组织化学和蛋白质印迹分析表明,RB1显著上调血红素加氧酶-1(HO-1)和Nrf2的蛋白表达,而ATRA处理可使其减弱。综上所述,这些结果表明RB1预处理对IIR诱导的肾损伤的保护作用与Nrf2/抗氧化反应元件(ARE)通路的激活有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/33a5f07d21fb/pone.0080859.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/b5ca6583eb57/pone.0080859.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/69d7aec04500/pone.0080859.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/92eebfa0ad50/pone.0080859.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/b77f3a3d7dc6/pone.0080859.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/bcb05cade6a8/pone.0080859.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/ce8201644eb8/pone.0080859.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/36f01022b2b4/pone.0080859.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/33a5f07d21fb/pone.0080859.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/b5ca6583eb57/pone.0080859.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/69d7aec04500/pone.0080859.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/92eebfa0ad50/pone.0080859.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/b77f3a3d7dc6/pone.0080859.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/bcb05cade6a8/pone.0080859.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/ce8201644eb8/pone.0080859.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/36f01022b2b4/pone.0080859.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1477/3851764/33a5f07d21fb/pone.0080859.g008.jpg

相似文献

1
Protective effect of ginsenoside Rb1 against intestinal ischemia-reperfusion induced acute renal injury in mice.人参皂苷Rb1对小鼠肠道缺血再灌注诱导的急性肾损伤的保护作用。
PLoS One. 2013 Dec 4;8(12):e80859. doi: 10.1371/journal.pone.0080859. eCollection 2013.
2
Ginsenoside Rb1 attenuates intestinal ischemia reperfusion induced renal injury by activating Nrf2/ARE pathway.人参皂苷 Rb1 通过激活 Nrf2/ARE 通路减轻肠缺血再灌注诱导的肾损伤。
Molecules. 2012 Jun 12;17(6):7195-205. doi: 10.3390/molecules17067195.
3
Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury following Intestinal Ischemia Reperfusion Injury in Mice.人参皂苷Rb1治疗减轻小鼠肠缺血再灌注损伤后的肺部炎性细胞因子释放和组织损伤。
Oxid Med Cell Longev. 2015;2015:843721. doi: 10.1155/2015/843721. Epub 2015 Jun 16.
4
Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion‑induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway.人参皂苷 Rb1 通过激活 PI3K/Akt/Nrf2 信号通路减轻肠缺血/再灌注诱导的炎症和氧化应激。
Mol Med Rep. 2019 May;19(5):3633-3641. doi: 10.3892/mmr.2019.10018. Epub 2019 Mar 12.
5
Ischemic postconditioning attenuates acute kidney injury following intestinal ischemia-reperfusion through Nrf2-regulated autophagy, anti-oxidation, and anti-inflammation in mice.缺血后处理通过 Nrf2 调控的自噬、抗氧化和抗炎减轻小鼠肠缺血再灌注后急性肾损伤。
FASEB J. 2020 Jul;34(7):8887-8901. doi: 10.1096/fj.202000274R. Epub 2020 Jun 10.
6
Neutrophil gelatinase-associated lipocalin (NGAL) may play a protective role against rats ischemia/reperfusion renal injury via inhibiting tubular epithelial cell apoptosis.中性粒细胞明胶酶相关脂质运载蛋白(NGAL)可能通过抑制肾小管上皮细胞凋亡对大鼠肾缺血再灌注损伤起保护作用。
Ren Fail. 2013;35(1):143-9. doi: 10.3109/0886022X.2012.741877. Epub 2012 Nov 15.
7
Regulation of Nrf2/A20/eEF1A2 Axis by Ginsenoside Rb1: A Key Pathway in Alleviating Cerebral Ischemia-Reperfusion Injury.人参皂苷 Rb1 调控 Nrf2/A20/eEF1A2 轴减轻脑缺血再灌注损伤的关键通路。
Discov Med. 2024 Aug;36(187):1743-1757. doi: 10.24976/Discov.Med.202436187.160.
8
Lipoxin A4 Preconditioning Attenuates Intestinal Ischemia Reperfusion Injury through Keap1/Nrf2 Pathway in a Lipoxin A4 Receptor Independent Manner.脂氧素A4预处理通过Keap1/Nrf2途径以不依赖脂氧素A4受体的方式减轻肠道缺血再灌注损伤。
Oxid Med Cell Longev. 2016;2016:9303606. doi: 10.1155/2016/9303606. Epub 2016 Jun 7.
9
Protective effect of N-(p-amylcinnamoyl) anthranilic acid, phospholipase A enzyme inhibitor, and transient receptor potential melastatin-2 channel blocker against renal ischemia-reperfusion injury.N-(对丙烯基肉桂酰)邻氨基苯甲酸、磷脂酶 A 酶抑制剂和瞬时受体电位 melastatin-2 通道阻滞剂对肾缺血再灌注损伤的保护作用。
J Cell Biochem. 2019 Mar;120(3):3822-3832. doi: 10.1002/jcb.27664. Epub 2018 Sep 27.
10
In vivo mechanism study of NGAL in rat renal ischemia-reperfusion injury.NGAL在大鼠肾缺血再灌注损伤中的体内机制研究
Genet Mol Res. 2014 Oct 27;13(4):8740-8. doi: 10.4238/2014.October.27.15.

引用本文的文献

1
H NMR metabonomic analysis of serum and flap tissue on the effect of ginsenoside Rb1 on survival of random pattern skin flaps in rats.H核磁共振代谢组学分析血清和皮瓣组织中人参皂苷Rb1对大鼠随意型皮瓣存活的影响。
Sci Rep. 2025 Mar 3;15(1):7416. doi: 10.1038/s41598-025-91798-z.
2
Ginsenoside Rb1 Improves Post-Cardiac Arrest Myocardial Stunning and Cerebral Outcomes by Regulating the Keap1/Nrf2 Pathway.人参皂苷 Rb1 通过调节 Keap1/Nrf2 通路改善心脏骤停后心肌顿抑和脑损伤。
Int J Mol Sci. 2023 Mar 6;24(5):5059. doi: 10.3390/ijms24055059.
3
Association between Consumption of Dietary Supplements and Chronic Kidney Disease Prevalence: Results of the Korean Nationwide Population-Based Survey.

本文引用的文献

1
N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats.N-乙酰半胱氨酸和别嘌醇通过恢复糖尿病大鼠 HIF-1α/HO-1 信号通路发挥协同作用,减轻心肌缺血损伤。
PLoS One. 2013 Jul 18;8(7):e68949. doi: 10.1371/journal.pone.0068949. Print 2013.
2
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.过氧化物酶体增殖物激活受体 δ 激动剂 HPP593 可预防慢性缺血引起的肾坏死。
PLoS One. 2013 May 15;8(5):e64436. doi: 10.1371/journal.pone.0064436. Print 2013.
3
Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients.
膳食补充剂的摄入与慢性肾脏病患病率的关系:来自韩国全国人群为基础的调查结果。
Nutrients. 2023 Feb 5;15(4):822. doi: 10.3390/nu15040822.
4
Renal function protection and the mechanism of ginsenosides: Current progress and future perspectives.人参皂苷的肾功能保护作用及其机制:当前进展与未来展望
Front Pharmacol. 2023 Feb 6;14:1070738. doi: 10.3389/fphar.2023.1070738. eCollection 2023.
5
Ginsenoside Rb1 improves energy metabolism after spinal cord injury.人参皂苷Rb1可改善脊髓损伤后的能量代谢。
Neural Regen Res. 2023 Jun;18(6):1332-1338. doi: 10.4103/1673-5374.357915.
6
Protective Effects and Mechanism of Radix Polygalae Against Neurological Diseases as Well as Effective Substance.远志对神经系统疾病的保护作用、机制及有效成分
Front Psychiatry. 2021 Dec 17;12:688703. doi: 10.3389/fpsyt.2021.688703. eCollection 2021.
7
Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective.人参(Panax Ginseng C.A.Mey.)作为药物:从药理学角度看人参作为肾脏保护药物的潜在用途。
Front Pharmacol. 2021 Aug 26;12:734151. doi: 10.3389/fphar.2021.734151. eCollection 2021.
8
Protective Effects and Network Analysis of Ginsenoside Rb1 Against Cerebral Ischemia Injury: A Pharmacological Review.人参皂苷Rb1对脑缺血损伤的保护作用及网络分析:药理学综述
Front Pharmacol. 2021 Jul 2;12:604811. doi: 10.3389/fphar.2021.604811. eCollection 2021.
9
A Systematic Review of Antiaging Effects of 23 Traditional Chinese Medicines.23种中药抗衰老作用的系统评价
Evid Based Complement Alternat Med. 2021 May 15;2021:5591573. doi: 10.1155/2021/5591573. eCollection 2021.
10
Mechanism of circadian regulation of the NRF2/ARE pathway in renal ischemia-reperfusion.肾脏缺血再灌注中NRF2/ARE通路的昼夜节律调节机制。
Exp Ther Med. 2021 Mar;21(3):190. doi: 10.3892/etm.2021.9622. Epub 2021 Jan 7.
临床综述:中性粒细胞明胶酶相关脂质运载蛋白对重症监护患者急性肾损伤的预测价值
Crit Care. 2013 Apr 24;17(2):211. doi: 10.1186/cc11855.
4
α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.α-硫辛酸通过激活 PI3K/Akt/Nrf2 通路减少大鼠心肌缺血/再灌注损伤中的梗死面积并保护心功能。
PLoS One. 2013;8(3):e58371. doi: 10.1371/journal.pone.0058371. Epub 2013 Mar 7.
5
Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes.鞣花酸通过上调 HO-1 和 Nrf-2 抗氧化基因保护人角质形成细胞(HaCaT)细胞免受 UVA 诱导的氧化应激和凋亡。
Food Chem Toxicol. 2012 May;50(5):1245-55. doi: 10.1016/j.fct.2012.02.020. Epub 2012 Feb 22.
6
The presence of oxidized low-density lipoprotein and inducible nitric oxide synthase expression in renal damage after intestinal ischemia reperfusion.肠缺血再灌注后肾损伤中氧化型低密度脂蛋白和诱导型一氧化氮合酶表达的存在。
Kaohsiung J Med Sci. 2012 Jan;28(1):16-22. doi: 10.1016/j.kjms.2011.06.030. Epub 2011 Dec 11.
7
Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats.人参皂苷Rb1预处理可增强糖尿病大鼠内皮型一氧化氮合酶(eNOS)的表达并减轻心肌缺血/再灌注损伤。
J Biomed Biotechnol. 2011;2011:767930. doi: 10.1155/2011/767930. Epub 2011 Oct 16.
8
Mechanism of the Nrf2/Keap1/ARE signaling system.Nrf2/Keap1/ARE 信号通路的作用机制。
Biochemistry (Mosc). 2011 Apr;76(4):407-22. doi: 10.1134/s0006297911040031.
9
Rb1 postconditioning attenuates liver warm ischemia-reperfusion injury through ROS-NO-HIF pathway.Rb1 后处理通过 ROS-NO-HIF 通路减轻肝脏热缺血再灌注损伤。
Life Sci. 2011 Mar 28;88(13-14):598-605. doi: 10.1016/j.lfs.2011.01.022. Epub 2011 Feb 12.
10
Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.Keap1-Nrf2 通路在应激反应和癌症演化中的分子机制。
Genes Cells. 2011 Feb;16(2):123-40. doi: 10.1111/j.1365-2443.2010.01473.x.